Literature DB >> 28082292

CML stem cells: evasion for better invasion.

Franck Emmanuel Nicolini1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28082292     DOI： 10.1182/blood-2016-11-750554

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

1.  Combination of Elacridar with Imatinib Modulates Resistance Associated with Drug Efflux Transporters in Chronic Myeloid Leukemia.

Authors:  Raquel Alves; Ana Cristina Gonçalves; Joana Jorge; António M Almeida; Ana Bela Sarmento-Ribeiro
Journal:  Biomedicines       Date:  2022-05-17

Review 2.  Immune Effector Recovery in Chronic Myeloid Leukemia and Treatment-Free Remission.

Authors:  Amy Hughes; Agnes S M Yong
Journal:  Front Immunol       Date:  2017-04-24       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.